Found 32 matching trials
Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients PHASE2 This is a prospective, Single arm Phase II trial. Patients were eligible to...
Show More Location
Chinese Academy of Medical Sciences
Learn More & Join Trial
: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors PHASE1 This is a phase Ib/II study to evaluate the safety, tolerability, PK profil...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer N/A The survival of the refractory CRC is dismal and therapy options are limite...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases PHASE2 Colorectal cancer (CRC) is a significant cause of morbidity and mortality w...
Show More Learn More & Join Trial
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma PHASE2 The goal of this prospective, interventional clinical trial is to evaluatio...
Show More Learn More & Join Trial
Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer N/A The purpose of this observational study is to understand the effect of gut ...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage PHASE2 A single-arm, phase II study was designed to evaluate the efficacy and safe...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression PHASE2 Efficacy and safety of fruquintinib in combination with sintilizumab and SB...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer PHASE2 This study is a single-arm, open-label, single-center clinical trial design...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) PHASE2 The study consists of two parts, the first part is a randomized, open-label...
Show More Status
Active Not Recruiting
Location
Beijing Chao-Yang Hospital, Capital Medical University
Learn More & Join Trial